戻る Agenda
Novel Therapeutic Approaches
Session Chair(s)
Dolca Thomas
Vice President Translational Medicine for Immunology, Inflammation and Infectiou
F. Hoffmann-La Roche, Switzerland
Many novel therapeutic approaches are on the horizon which the promise to address the unmet needs of patients. However, some of these approaches will challenge current approaches to drug development, regulation and the health technology assessment. A multi-stakeholder round table.
Speaker(s)
Panel Discussion
Tomasz Lawniczek, DrMed
Novartis, Switzerland
Senior Clinical Development Medical Director
Panel Discussion
Sheuli Porkess, MD, MRCP, FFPM
The Association of the British Pharmaceutical Industry (ABPI), United Kingdom
Executive Director Research, Medical & Innovation
Panel Discussion
Corinne de Vries, PhD, MA, MSc
European Medicines Agency, Netherlands
EMA liaison official to the US FDA
Panel Discussion
Niklas Hedberg, MPharm
Dental and Pharmaceutical Benefits Agency, TLV, Sweden
HTACG Co-Chair & Chief Pharmacist